Last reviewed · How we verify

NCT07058376

Clinical Research of Effectiveness and Safety of Herbal Medicine Strategy for Chronic Low Back Pain

ENROLLING BY INVITATION NA Last updated 19 November 2025
What this trial tests

NA trial testing Herbal Medicine Strategy in Chronic Low-back Pain (cLBP) in 150 participants. Enrolling by invitation.

Timeline
31 October 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorJaseng Medical Foundation
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment150
Start date31 October 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Jaseng Medical Foundation

Who can join

Adults 19 to 69, any sex, with Chronic Low-back Pain (cLBP). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a pragmatic multicenter randomized controlled trial evaluating the effectiveness and safety of herbal medicine strategy for chronic low back pain, using standard Korean medicine treatment as the control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Low-back Pain (cLBP)

Currently open trials in the same condition.

Other Jaseng Medical Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07058376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing